Genetic risk factors in acute coronary disease

Haemostasis

Volumn 29, Issue 4, 1999, Pages 212-218

  Araújo, Fernando ^a,c   Santos, A ^b   Araujo V ^c   Henriques, I ^a   Monteiro, F ^a   Meireles, E ^a   Moreira, I ^b   David, D ^b   Maciel, M J ^c   Cunha Ribeiro, L M ^a  

^a Molecular Biology Unit   (Portugal)

^b National Health Institute Dr Ricardo Jorge   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Factor V Leiden; Glycoprotein IIb IIIa; Methylene tetrahydrofolate reductase gene mutation; Multigenic disorder; Myocardial infarction; Prothrombin polymorphism; Unstable angina

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; PROTHROMBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

EID: 0343920823     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022504     Document Type: Article

References (22)

1. 33 amino acid polymorphism in membrane glycoprotein IIIa. and are distinguishable by DNA typing. J Clin Invest 1989;83: 1778-1781.
2. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ: A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-1094.
3. Garcia-Ribes M, Gonzalez-Lamuno D, Hernandez-Estefania R, Colman T, Pocovi M, Delgado-Rodriguez M, Garcia-Fuentes M, Revuelta JM: Polymorphism of the platelet glycoprotein IIIa gene in patients with coronay stenosis. Thromb Haemost 1998;79:1126-1129.
4. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994:369:64-67.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88: 3698-3703.
6. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzachi JM, Costa FF: The mutation ALA677Val in the methylene tetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997;77:818-821.
7. Souto JC, Coll I, Lloblet D, del Rio E, Oliver A, Mateo J, Borrell M. Fontcuberta J: The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb Haemost 1998;80: 366-369.
8. Zenz W, Bodo Z, Plotho J, Streif W, Male C, Bernert G, Rauter L, Ebetsberger G, Kaltenbrunner K, Kurnik P, Lischka A, Paky F, Ploier R, Hofler G, Mannhalter C, Muntean W: Factor V Leiden and prothrombin gene 20210 A variant in children with ischemic stroke. Thromb Haemost 1998;80:763-766.
9. Iniesta JA, Corral J, Pardo JF, Conejero AG, Vicente V: Factor V (Arg506-Gln) mutation in ischemic cerebrovascular disease. Haemostasis 1997;27:105-111.
10. Arruda VR, Annichino-Bizzacchi A, Gonçalves MS, Costa FF: Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997;78:1430-1433.
11. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT, Raghunathan TE, Koepsell TD, Reitsma PH: Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-2821.
12. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL: A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997;90:1747-1750.
13. Ying J, Dietz HC, Nurden A, Bray PF: Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993:82:2281-2288.
14. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet 1997;349:385-388.
15. A2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Thromb Haemost 1997;77: 1179-1181.
16. Newman PJ: Platelet alloantigens: Cardiovascular as well as immunological risk factors? Lancet 1997; 349:370-371.
17. Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH: Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-708.
18. Zabalegui N, Montes R, Orbe R, Ayape ML, Medarde A, Páramo JA, Rocha E: Prevalence of the FVR to Q and Prothrombin 20210A mutations in the Navarrese population. Thromb Haemost 1998;80:522-523.
19. Franco RF, Trip MD, ten Cate H, Prins MH, Kastelein JJP, Reitsma PH: The prevalence of the 20210 G to A mutation in the 3′-untranslated region of the prothrombin gene in patients with premature coronary artery disease (abstract). Thromb Haemost 1997;78:769-770.
20. Watzke HH, Schuttrumpf J, Graf S, Huber K, Panzer S: Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res 1997;87:521-526.
21. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ: Co-inheritance of the 20210 allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997;78:1426-1429.
22. Pastinen T, Perola M, Niini P, Terwilliger J, Salomaa V, Vartiainen E, Peltonen L, Syvanen AC: Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet 1998; 7:1453-1462.